Electromed (NYSE:ELMD) Downgraded to Buy at StockNews.com

StockNews.com cut shares of Electromed (NYSE:ELMD) from a strong-buy rating to a buy rating in a research note issued to investors on Thursday.

Separately, TheStreet raised shares of Electromed from a c+ rating to a b- rating in a report on Wednesday, February 21st.

Electromed Stock Down 1.3 %

Shares of Electromed stock opened at $13.94 on Thursday. Electromed has a twelve month low of $8.80 and a twelve month high of $17.85. The company has a 50-day simple moving average of $15.25 and a two-hundred day simple moving average of $12.10. The stock has a market capitalization of $120.02 million, a price-to-earnings ratio of 30.98 and a beta of 0.43.

Electromed (NYSE:ELMD) last posted its earnings results on Tuesday, February 13th. The company reported $0.19 earnings per share for the quarter. Electromed had a net margin of 7.62% and a return on equity of 10.32%. The firm had revenue of $13.69 million for the quarter.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of ELMD. Cetera Advisor Networks LLC acquired a new position in shares of Electromed in the 2nd quarter worth approximately $129,000. State Street Corp lifted its position in shares of Electromed by 8.3% during the 2nd quarter. State Street Corp now owns 15,736 shares of the company’s stock valued at $152,000 after acquiring an additional 1,207 shares during the period. BlackRock Inc. lifted its position in shares of Electromed by 7.6% during the 2nd quarter. BlackRock Inc. now owns 20,521 shares of the company’s stock valued at $220,000 after acquiring an additional 1,452 shares during the period. Gabelli Funds LLC raised its holdings in Electromed by 17.3% during the fourth quarter. Gabelli Funds LLC now owns 20,367 shares of the company’s stock worth $222,000 after buying an additional 3,000 shares during the last quarter. Finally, Northern Trust Corp raised its holdings in Electromed by 4.7% during the second quarter. Northern Trust Corp now owns 29,078 shares of the company’s stock worth $311,000 after buying an additional 1,306 shares during the last quarter. Institutional investors and hedge funds own 40.82% of the company’s stock.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.